SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Cassava Sciences, Inc. (SAVA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

/EIN News/ -- ATLANTA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or “the Company”) (NASDAQ: SAVA). The lawsuit alleges that Defendants created a false impression that they possessed reliable information pertaining to the Company’s drug prospects and anticipated growth while also minimizing risk from a potential drug failure.

If you bought shares of Cassava between February 7, 2024 to November 24, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/cassava/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is February 10, 2025.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com